{"database": "lobbying", "table": "lobbying_activities", "rows": [[2262716, "10cf70d8-c4df-493d-875d-090790e30e1a", "Q1", "IPOLICY SOLUTIONS", 401105127, "SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4))", 2019, "first_quarter", "MED", "No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act\nDraft Guidance: Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeutic Products", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2019-04-08T18:00:16.177000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2262716"], "units": {}, "query_ms": 9.553589014103636, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}